NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals

NIIMBL and The Open Applications Group have partnered to develop #biopharma #manufacturing ontologies as an open-source project, allowing for greater participation and adoption. Check out this recent article in Genetic Engineering & Biotechnology News highlighting this partnership and the benefits of #data standardization. https://lnkd.in/eFnZvUxp

What does the future of #biopharma #manufacturing look like? How do we get there? Our panel of experts from Cytiva, Boehringer Ingelheim, MilliporeSigma, Sartorius, and Vir Biotechnology, Inc. tackled those questions during our Visions and Challenges panel on Wednesday during the National Meeting.

Our 2024 NIIMBL National Meeting got off to a fantastic start yesterday with remarks for National Institute of Standards and Technology (NIST) Director Laurie Locascio, FDA Acting Chief Scientist David Strauss, and FDA CBER Director Peter Marks. Then, we had a full day of concurrent sessions focused on topics such as #bigdata, the #biopharma #manufacturing factory of the future, ontologies, inclusive #workforcedevelopment, and more. Our National Meeting brings the NIIMBL community together for plenty of thought-provoking discussion. We look forward much of the same this week in Washington, D.C. #biopharmaceuticals #biopharma #lifesciences #biomanufacturing #biotechnology #biotech

Our National Meeting week in Washington, D.C. kicked off with our Dancing with Venture event on Monday afternoon, connecting member small and medium-sized companies with venture capitalists in the #lifesciences. In addition to pitches from our SMM community and introductions from investors, the event featured fascinating perspectives and insights from our SMM panel discussion, fireside chat, and managing cash flow session. Thank you to our SMM panelists Nicole Merli, MBA, CRA (LumaCyte), Alina Alexeenko (LyoWave, Inc.), Erica Dawson (InDevR, Inc.), and Lena Wu (Phizzle), our Fireside Chat participants Daniella Kranjac (AVANT BIO) and John Bagdonas, CEP, FGE, NDEF (J.P. Morgan), and managing cash flow speakers Fletcher King and James Fitzgerald (Morgan Stanley), as well as our opening speaker Jorge Lamboy, PhD (National Institute of Standards and Technology (NIST) #biotech #biopharmaceuticals #biomanufacturing

We are excited to share we have contributed biopharmaceutical manufacturing ontologies to Open Applications Group for further development as an open-source project. Ontologies are semantic information models tailored for domain experts with clear, formal, and natural language definitions and labels. It represents a data domain through entities, their relations to each other, and literal values. “These biopharma-specific ontologies will improve interoperability and optimize productivity by allowing data engineers to access, analyze, and share data about their manufacturing processes,” said Roger Hart, NIIMBL Senior Fellow and Big Data Project Lead. “The open-source platform will ensure industry access to the ontologies and allow for continued development and modifications. It will also provide a centralized repository to collect and curate ontologies which are currently privately created and used by small groups within the community.” You can get involved in the continued development of biopharma ontologies by joining OAGi's Industry Ontology Foundry. Find more information in the full release: https://lnkd.in/efjYESZb #biopharma #biopharmaceuticals #lifesciences #bigdata #ontology #bioprocess #biomanufacturing #data

#NIIMBLeXperience2024 is in full swing this week with four programs happening at Albany College of Pharmacy and Health Sciences, Thomas Jefferson University (Jefferson Institute for Bioprocessing), NC State BTEC, and the University of Houston and another set for later in June at Santa Clara University. We look forward to introducing 60 talent students to careers in the #biopharma industry. #NIIMBLeXperience2024 #NIIMBLeXperienceACPHS #NIIMBLeXperienceNCState #NIIMBLeXperienceSCU #NIIMBLeXperienceTJU #NIIMBLeXperienceUH #biotech #talent #workforceofthefuture #STEM #biopharmaceuticalmanufacturing #diversity #futureofbiopharmamanufacturing #niimbl https://lnkd.in/edS6Ge8D

The NIIMBL eXperience offers first and second year college students from underrepresented populations a glimpse into the multitude of career pathways in the biopharma industry. Do you want to play a key role in introducing the next group of talented STEM-focused students to this transformative industry? The 2025 NIIMBL eXperience Request for Applications is now open. We are seeking NIIMBL academic or non-profit member organizations to serve as regional lead organizations that will plan, recruit students, and run a NIIMBL eXperience program in their region during the summer of 2025. Learn more and register for our June 18 listening session: https://lnkd.in/eTXhzc8Y #NIIMBLeXperience2025 #biopharma #biopharmaceuticals #workforcedevelopment #lifesciences #STEM #biomanufacturing #biotechnology

LAST DAY: Early bird registration for the 2024 National Meeting closes today. Don't miss your chance to join us in Washington, D.C. at the early bird rate. https://lnkd.in/eTJgM_nh

NIIMBL bioLOGIC helps high school students gain insight into what it takes to bring new #biopharma products to the market. Thanks to the amazing students and staff at The Charter School of Wilmington for their enthusiastic participation in the program this year. https://lnkd.in/emfue_j3

Attention small and medium-sized companies: Have you registered for Dancing with Venture yet? This exclusive event for NIIMBL member small and medium-sized companies gives you the chance to showcase your technology to venture capitalists who invest in the #lifesciences industry. Plus you won't want to miss a special the opening "De-risking Cash for Companies and Their Founders" session with speakers from Morgan Stanley. Learn more and register: https://lnkd.in/e8_bnHvF #biotech #venturecapital #biotechnology #science #pharma #biopharma